GSK3B and nasopharyngeal carcinoma: To further test whether EZH2 was involved in the enhanced invasion of NPC cell lines followed by GSK3β inactivation, we transfected EZH2 siRNA into NPC cells to inhibit EZH2 expression under different conditions.